Skip to main content
SpringerLink
Log in

Follow-up of Patients with Differentiated Thyroid Carcinoma

  • Chapter
Book cover Practical Management of Thyroid Cancer

  • 827 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Schlumberger MJ. Medical progress: papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338:297–306.

    Article  PubMed  CAS  Google Scholar 

  2. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents, Vol. VII. Lyon: IARC Scientific Publications No 143, 1997.

    Google Scholar 

  3. Colonna M, Grosclaude P, Remontet L, et al. Incidence of thyroid cancer in adults recorded by French Cancer registries (1978–1997). Eur J Cancer 2002; 38:1762–1768.

    Article  PubMed  CAS  Google Scholar 

  4. Leenhardt L, Bernier MO, Boin-Pineau MH, et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol 2004; 50:133–139.

    Article  Google Scholar 

  5. Schlumberger M, Berg G, Cohen O, et al. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 2004; 50:105–112.

    Article  Google Scholar 

  6. Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 1433–1441.

    Article  PubMed  CAS  Google Scholar 

  7. Schlumberger MJ, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996; 37:598–605.

    PubMed  CAS  Google Scholar 

  8. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137:909–914.

    Google Scholar 

  9. Schlumberger MJ, Pacini F. Thyroid tumors, 2nd edn. Paris: Editions Nucleon, 2003.

    Google Scholar 

  10. Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin antibodies: prevalence, influence on serum thyroglobulin measurements, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83:1121–1127.

    Article  PubMed  CAS  Google Scholar 

  11. Chiovato L, Latrofa F, Braverman LE, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003; 139: 346–351.

    PubMed  CAS  Google Scholar 

  12. Bartalena L, Martino E, Pacchiarotti A, et al. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients J Clin Endocrinol Metab 1987; 64:849–855.

    Article  PubMed  CAS  Google Scholar 

  13. Torlontano M, Crocetti U, D’Aloiso L, et al. Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. The role for neck ultrasonography. Eur J Endocrinol 2003; 148:18–24.

    Article  Google Scholar 

  14. David A, Blotta A, Bondanelli M, et al. Serum thyroglobulin concentrations and 131I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroidstimulating hormone. J Nucl Med 2001; 42:1470–1475.

    PubMed  CAS  Google Scholar 

  15. Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999; 84:3877–3885.

    Article  PubMed  CAS  Google Scholar 

  16. Haugen BR, Ridgway EC, McLaughlin B, McDermott MT. Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human TSH. Thyroid 2002; 12:37–43.

    Article  PubMed  CAS  Google Scholar 

  17. Ladenson PW, Braverman LE, Mazzaferri EL, et al. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 1997; 337:888–896.

    Article  PubMed  CAS  Google Scholar 

  18. Mazzaferri EL, Kloos RT. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the followup of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 2002; 87:1490–1498.

    Article  PubMed  CAS  Google Scholar 

  19. Meier CA, Braverman LE, Ebner SA, et al. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I/II Study). J Clin Endocrinol Metab 1994; 78:188–196.

    Article  PubMed  CAS  Google Scholar 

  20. Pacini F, Molinaro E, Castagna MG, et al. rhTSH-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003; 88:3668–3673.

    Article  PubMed  CAS  Google Scholar 

  21. Robbins RJ, Chon JT, Fleisher M, Larson SM, Tuttle RM. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 2002; 87:3242–3247.

    Article  PubMed  CAS  Google Scholar 

  22. Wartofsky L. Management of low risk well-differentiated thyroid cancer based only upon thyroglobulin measurement after recombinant human thyrotropin. Thyroid 2002; 12:583–590.

    Article  PubMed  CAS  Google Scholar 

  23. Pacini F, Molinaro E, Lippi F, et al. Prediction of disease status by recombinant human TSH stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma. J Clin Endocrinol Metab 2001; 86:5686–5690.

    Article  PubMed  CAS  Google Scholar 

  24. Dow KH, Ferrell BR, Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 1997; 7:613–619.

    PubMed  CAS  Google Scholar 

  25. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab 2000; 85:175–178.

    Article  PubMed  CAS  Google Scholar 

  26. Pacini F, Capezzone M, Elisei R, Ceccarelli C, Taddei D, Pinchera A. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 2002; 87:1499–1501.

    Article  PubMed  CAS  Google Scholar 

  27. Torlontano M, Attard M, Crocetti U, et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 2004; 89:3402–3407.

    Article  PubMed  CAS  Google Scholar 

  28. Park HM, Perkins OW, Edmondson JW, Schnute RB, Manatunga A. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131. Thyroid 1994; 4:49–54.

    PubMed  CAS  Google Scholar 

  29. Postgard P, Jimmelman J, Lindencrona U, et al. Stunning of iodine transport by (131)I irradiation in cultured thyroid epithelial cells. J Nucl Med 2002; 43:828–834.

    PubMed  CAS  Google Scholar 

  30. Frasoldati A, Presenti M, Gallo M, Caroggio A, Salvo D, Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 2003; 97: 90–96.

    Article  PubMed  Google Scholar 

  31. Bachelot A, Cailleux AF, Klain M, et al. Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 2002; 12:707–711.

    Article  PubMed  CAS  Google Scholar 

  32. Demers LM, Spencer CA. 7-13-2002 Laboratory support for the diagnosis and monitoring of thyroid disease. <http://www.nacb.org/lmpg/thyroid/LMPH.stm>.

    Google Scholar 

  33. Pacini F, Fugazzola L, Lippi F, et al. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. J Clin Endocrinol Metab 1992; 74: 1401–1404.

    Article  PubMed  CAS  Google Scholar 

  34. Frasoldati A, Toschi E, Zini M, et al. Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer. Thyroid 1999; 9:105–111.

    Article  PubMed  CAS  Google Scholar 

  35. Arturi F, Russo D, Giuffrida D, et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 1997; 82:1638–1641.

    Article  PubMed  CAS  Google Scholar 

  36. Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal in thyroid cancer patients. J Clin Endocrinol Metab 2003; 88:1107–1111.

    Article  PubMed  CAS  Google Scholar 

  37. Pacini F, Agate L, Elisei R, et al. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic 131I whole body scan: comparison of patients treated with high 131I activities versus untreated patients. J Clin Endocrinol Metab 2001; 86:4092–4097.

    Article  PubMed  CAS  Google Scholar 

  38. Petrich T, Börner AR, Otto D, Hofmann M, Knapp WH. Influence of rhTSH on [18F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 2002; 29:641–647.

    Article  PubMed  CAS  Google Scholar 

  39. Chin BB, Patel P, Cohade C, Ewertz M, Wahl R, Ladenson P. Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 2004; 89:91–95.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Endocrine Tumours, Institut Gustave Roussy, Villejuif, France

    Martin J. Schlumberger MD & Sophie M. Leboulleux MD

  2. Department of Internal Medicine, Endocrinology and Metabolism, and Biochemistry, University of Siena, Siena, Italy

    Furio Pacini MD

Authors
  1. Martin J. Schlumberger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sophie M. Leboulleux MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Furio Pacini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Ohio State University, Columbus, OH, USA

    Ernest L. Mazzaferri MD, MACP (Emeritus Professor) (Emeritus Professor)

  2. University of Florida, Gainsville, FL, USA

    Ernest L. Mazzaferri MD, MACP (Emeritus Professor) (Emeritus Professor)

  3. Department of Radiotherapy, Royal Marsden Hospital, London, UK

    Clive Harmer FRCR, FRCP (Head of Thyroid Unit) (Head of Thyroid Unit)

  4. Northern Centre for Cancer Treatment, Newcastle upon Tyne, UK

    Ujjal K. Mallick MS, FRCR (Vice-Chair) (Vice-Chair)

  5. Thyroid Cancer Subgroup, National Cancer Research Institute, UK

    Ujjal K. Mallick MS, FRCR (Vice-Chair) (Vice-Chair)

  6. Northern Cancer Network Thyroid Cancer Group, UK

    Ujjal K. Mallick MS, FRCR (Vice-Chair) (Vice-Chair)

  7. Department of Medicine, University of Newcastle upon Tyne, UK

    Pat Kendall-Taylor MD, FRCP (Emeritus Professor) (Emeritus Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Schlumberger, M.J., Leboulleux, S.M., Pacini, F. (2006). Follow-up of Patients with Differentiated Thyroid Carcinoma. In: Mazzaferri, E.L., Harmer, C., Mallick, U.K., Kendall-Taylor, P. (eds) Practical Management of Thyroid Cancer. Springer, London. https://doi.org/10.1007/1-84628-013-3_19

Download citation

  • DOI: https://doi.org/10.1007/1-84628-013-3_19

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-910-4

  • Online ISBN: 978-1-84628-013-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation